Cargando…

Development of a Virus-Like Particle-Based Anti-HER2 Breast Cancer Vaccine

SIMPLE SUMMARY: Virus-like particles (VLPs) have attracted significant interest as immunotherapy platforms and cancer vaccines for inducing antigen-specific immune responses against tumors. We prepared a human epidermal growth factor receptor-2 (HER2) cancer vaccine, by conjugating the HER2-derived...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, He, Steinmetz, Nicole F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230452/
https://www.ncbi.nlm.nih.gov/pubmed/34200802
http://dx.doi.org/10.3390/cancers13122909